β受体激动剂与哮喘：好事过头了？
Beta-agonists and asthma: too much of a good thing?
作者信息
Shore Stephanie A, Drazen Jeffrey M
机构信息
Physiology Program, Harvard School of Public Health, 665 Huntington Avenue, Boston, Massachusetts 02115, USA.
出版信息
J Clin Invest. 2003 Aug;112(4):495-7. doi: 10.1172/JCI19642.
Abstract
In an unusual paradox, asthmatics who are chronically treated with bronchodilating beta-agonists sometimes experience a worsening of their condition. A new study describes one possible mechanism and reveals a potential new therapeutic target in the treatment of asthma.
摘要
在一个不同寻常的矛盾现象中，长期接受支气管扩张β受体激动剂治疗的哮喘患者有时病情会恶化。一项新研究描述了一种可能的机制，并揭示了哮喘治疗中一个潜在的新治疗靶点。
相似文献
1
Beta-agonists and asthma: too much of a good thing?β受体激动剂与哮喘：好事过头了？
J Clin Invest. 2003 Aug;112(4):495-7. doi: 10.1172/JCI19642.
2
Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.第四部分：β2 肾上腺素能受体的基因变异：长效和短效β2 激动剂与治疗反应
Curr Med Res Opin. 2007 Sep;23 Suppl 3:S29-36. doi: 10.1185/030079907.
3
Risk versus benefit considerations for the beta(2)-agonists.β2受体激动剂的风险与获益考量
Pharmacotherapy. 2006 Sep;26(9 Pt 2):164S-74S. doi: 10.1592/phco.26.9part2.164S.
4
[Potentiation of the bronchodilating effect of beta-adrenergic agonists in guinea pigs with ketotifen].[酮替芬对豚鼠β-肾上腺素能激动剂支气管舒张作用的增强]
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi. 1986 Aug;9(4):242-4, 256.
5
Long-acting beta-2 agonists in asthma.哮喘治疗中的长效β2受体激动剂
Med Lett Drugs Ther. 2009 Jan 12;51(1303):1-2.
6
Safety and efficacy of beta agonists.
Respir Care. 2008 May;53(5):618-22; discussion 623-4.
7
Beta2 agonists in the treatment of asthma.β2受体激动剂在哮喘治疗中的应用。
Am Fam Physician. 2006 Jul 15;74(2):232.
8
[beta2-Sympathomimetics: dangers in asthma therapy? Lessons from the SMART1 Study].
Dtsch Med Wochenschr. 2007 Mar 23;132(12):633; author reply 633-4. doi: 10.1055/s-2007-973592.
9
Beta 2 agonists in asthma: relief, prevention, morbidity.哮喘治疗中的β2激动剂：缓解、预防与发病率
Lancet. 1990 Dec 8;336(8728):1411-2.
10
The proper role of beta 2-adrenergic agonists in the treatment of children with asthma.
Pediatrics. 1992 Oct;90(4):639-40.
引用本文的文献
1
Oxylipin Profiling of Airway Structural Cells Is Unique and Modified by Relevant Stimuli.气道结构细胞的氧化脂质谱具有独特性，并会受到相关刺激的影响而发生改变。
J Proteome Res. 2025 Feb 7;24(2):672-684. doi: 10.1021/acs.jproteome.4c00775. Epub 2025 Jan 3.
2
Respiratory syncytial virus induces β-adrenergic receptor dysfunction in human airway smooth muscle cells.呼吸道合胞病毒诱导人呼吸道平滑肌细胞β肾上腺素能受体功能障碍。
Sci Signal. 2021 Jun 1;14(685):eabc1983. doi: 10.1126/scisignal.abc1983.
3
Effects of β-blockers on house dust mite-driven murine models pre- and post-development of an asthma phenotype.β-受体阻滞剂对尘螨驱动的哮喘表型发生前和发生后小鼠模型的影响。
Pulm Pharmacol Ther. 2017 Oct;46:30-40. doi: 10.1016/j.pupt.2017.07.004. Epub 2017 Jul 17.
4
Heat Shock-Related Protein 20 Peptide Decreases Human Airway Constriction Downstream of β2-Adrenergic Receptor.热休克相关蛋白20肽在β2-肾上腺素能受体下游减轻人类气道收缩
Am J Respir Cell Mol Biol. 2016 Aug;55(2):225-33. doi: 10.1165/rcmb.2015-0139OC.
5
Defective Resensitization in Human Airway Smooth Muscle Cells Evokes β-Adrenergic Receptor Dysfunction in Severe Asthma.人气道平滑肌细胞中再敏化缺陷引发重症哮喘中的β-肾上腺素能受体功能障碍。
PLoS One. 2015 May 29;10(5):e0125803. doi: 10.1371/journal.pone.0125803. eCollection 2015.
6
β2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model.β2-肾上腺素受体激动剂是在小鼠模型中发展哮喘表型所必需的。
Am J Respir Cell Mol Biol. 2013 Feb;48(2):220-9. doi: 10.1165/rcmb.2012-0364OC. Epub 2012 Nov 29.
7
In vitro and in vivo pharmacological profile of PL-3994, a novel cyclic peptide (Hept-cyclo(Cys-His-Phe-d-Ala-Gly-Arg-d-Nle-Asp-Arg-Ile-Ser-Cys)-Tyr-[Arg mimetic]-NH(2)) natriuretic peptide receptor-A agonist that is resistant to neutral endopeptidase and acts as a bronchodilator.新型环肽（Hept-cyclo（Cys-His-Phe-d-Ala-Gly-Arg-d-Nle-Asp-Arg-Ile-Ser-Cys）-Tyr-[Arg 类似物]-NH（2））PL-3994 的体外和体内药理学特性，是一种对中性内肽酶有抗性且作为支气管扩张剂的利钠肽受体-A 激动剂。
Pulm Pharmacol Ther. 2013 Apr;26(2):229-38. doi: 10.1016/j.pupt.2012.11.001. Epub 2012 Nov 12.
8
Iron supplementation decreases severity of allergic inflammation in murine lung.铁补充剂可降低小鼠肺部过敏炎症的严重程度。
PLoS One. 2012;7(9):e45667. doi: 10.1371/journal.pone.0045667. Epub 2012 Sep 20.
9
G-protein coupled receptor resensitization-appreciating the balancing act of receptor function.G蛋白偶联受体再敏化——认识受体功能的平衡行为
Curr Mol Pharmacol. 2012 May 30.
10
A novel EST-derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in β2-adrenergic receptor internalization and down-regulation.一种新的 EST 衍生的 RNAi 筛选揭示了法呢基二磷酸合酶在β2-肾上腺素能受体内化和下调中的关键作用。
FASEB J. 2012 May;26(5):1995-2007. doi: 10.1096/fj.11-193870. Epub 2012 Jan 25.
本文引用的文献
1
Antithetic regulation by beta-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway beta-agonist paradox.β-肾上腺素能受体通过磷脂酶C对Gq受体信号传导的反向调节是气道β-激动剂悖论的基础。
J Clin Invest. 2003 Aug;112(4):619-26. doi: 10.1172/JCI18193.
2
The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.G蛋白偶联受体与β-抑制蛋白相互作用的稳定性决定了细胞外信号调节激酶（ERK）激活的机制和功能后果。
J Biol Chem. 2003 Feb 21;278(8):6258-67. doi: 10.1074/jbc.M212231200. Epub 2002 Dec 6.
3
Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling.糖皮质激素与β2激动剂通过同步细胞信号传导对支气管气道平滑肌细胞产生的相互作用。
Lancet. 2002 Oct 26;360(9342):1293-9. doi: 10.1016/S0140-6736(02)11319-5.
4
Regulation of G protein-coupled receptor signaling by scaffold proteins.支架蛋白对G蛋白偶联受体信号传导的调控。
Circ Res. 2002 Oct 18;91(8):672-80. doi: 10.1161/01.res.0000037000.74258.03.
5
Beta-agonist intrinsic efficacy: measurement and clinical significance.β-激动剂内在活性：测量与临床意义
Am J Respir Crit Care Med. 2002 May 15;165(10):1353-8. doi: 10.1164/rccm.2109060.
6
Glucocorticoids reverse IL-1beta-induced impairment of beta-adrenoceptor-mediated relaxation and up-regulation of G-protein-coupled receptor kinases.糖皮质激素可逆转白细胞介素-1β诱导的β-肾上腺素能受体介导的舒张功能障碍以及G蛋白偶联受体激酶的上调。
Br J Pharmacol. 2002 Feb;135(4):987-96. doi: 10.1038/sj.bjp.0704545.
7
Inhibitors of mitogen-activated protein kinases differentially regulate eosinophil-activating cytokine release from human airway smooth muscle.丝裂原活化蛋白激酶抑制剂对人气道平滑肌释放嗜酸性粒细胞激活细胞因子具有不同的调节作用。
Am J Respir Crit Care Med. 2001 Aug 15;164(4):688-97. doi: 10.1164/ajrccm.164.4.2011004.
8
Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes.β2-肾上腺素能信号通路对成年小鼠心肌细胞存活与细胞死亡的双重调控
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1607-12. doi: 10.1073/pnas.98.4.1607.
9
Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids.β2 激动剂和皮质类固醇对肿瘤坏死因子-α 诱导培养的人气道平滑肌细胞释放嗜酸性粒细胞趋化因子的调节作用
FASEB J. 2001 Jan;15(1):261-269. doi: 10.1096/fj.00-0103com.
10
Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.长期使用β受体激动剂期间的哮喘急性加重：β₂肾上腺素能受体基因多态性的影响
Thorax. 2000 Sep;55(9):762-7. doi: 10.1136/thorax.55.9.762.
Zotero 插件